All Pharma News
price-trendAsk Us
Accent Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting

Accent Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting
PR NEWSWIRE
08 Apr 2024
Share Share
Accent to Present Data DHX9 and KIF18A as Compelling Therapeutic Targets at AACR

Accent to Present Data DHX9 and KIF18A as Compelling Therapeutic Targets at AACR
PR NEWSWIRE
21 Mar 2024
Share Share
Accent Therapeutics Announces $75 Million Series C Financing

Accent Therapeutics Announces $75 Million Series C Financing
PR NEWSWIRE
23 Jan 2024
Share Share
Two more pharmas invest in Accent, joining $75M series C round

Two more pharmas invest in Accent, joining $75M series C round
FIERCE BIOTECH
23 Jan 2024
Share Share
Accent Therapeutics Unveils XRN1 Program

Accent Therapeutics Unveils XRN1 Program
PR NEWSWIRE
10 Oct 2023
Share Share
Accent Therapeutics Bolsters Leadership Team with Key Executive Hires

Accent Therapeutics Bolsters Leadership Team with Key Executive Hires
PR NEWSWIRE
21 Sep 2023
Share Share
Accent Therapeutics to Present Data Supporting DHX9 Inhibition at AACR Meeting

Accent Therapeutics to Present Data Supporting DHX9 Inhibition at AACR Meeting
PR NEWSWIRE
06 Apr 2023
Share Share
Langer, Ciechanover godfather the latest AI upstart; & more

Langer, Ciechanover godfather the latest AI upstart; & more
John Carroll\nMax Gelman ENDPTS
18 Oct 2021
Share Share
Accent Appoints Julie Hambleton to its Board of Directors

Accent Appoints Julie Hambleton to its Board of Directors
BUSINESSWIRE
25 Sep 2020
Share Share
Accent, AstraZeneca take aim at RNA modifiers in $55M pact

Accent, AstraZeneca take aim at RNA modifiers in $55M pact
A. Al Idrus FIERCE BIOTECH
04 Jun 2020
Share Share